Source: ALL
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.100 | None | 0.938 | 48 | 7 | 1999 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.100 | None | 1.000 | 12 | 6 | 2004 | 2018 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
disease | 0.020 | None | 1.000 | 2 | 6 | 2005 | 2006 | ||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
disease | 0.400 | moderate | 1.000 | 43 | 4 | 1999 | 2019 | ||||||||
|
thiopurine S-methyltransferase | 0.593 | 0.692 | 7.1E-06 |
|
disease | 0.100 | None | 0.964 | 28 | 4 | 1998 | 2020 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase | 0.482 | 0.808 | 2.4E-12 |
|
disease | 0.060 | None | 1.000 | 6 | 4 | 2002 | 2012 | ||||||||
|
solute carrier family 19 member 1 | 0.523 | 0.692 | 6.5E-06 |
|
disease | 0.040 | None | 1.000 | 4 | 4 | 1998 | 2014 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.100 | None | 0.970 | 100 | 3 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.400 | limited | 0.977 | 43 | 3 | 1994 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.862 | 29 | 3 | 1989 | 2019 | ||||||||
|
inosine triphosphatase | 0.604 | 0.500 | 1.0E-07 |
|
disease | 0.080 | None | 1.000 | 8 | 3 | 2009 | 2019 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 3 | 2013 | 2019 | ||||||||
|
folylpolyglutamate synthase | 0.644 | 0.423 | 1.2E-06 |
|
disease | 0.040 | None | 1.000 | 4 | 3 | 1997 | 2014 | ||||||||
|
LIM domain only 1 | 0.623 | 0.538 | 0.64 |
|
disease | 0.020 | None | 1.000 | 2 | 3 | 2011 | 2017 | ||||||||
|
nibrin | 0.467 | 0.808 | 2.2E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 3 | 2006 | 2011 | ||||||||
|
folate hydrolase 1 | 0.453 | 0.885 | 6.2E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 3 | 2012 | 2012 | ||||||||
|
CCAAT enhancer binding protein epsilon | 0.674 | 0.385 | 7.1E-03 |
|
disease | 0.060 | None | 1.000 | 6 | 2 | 2013 | 2019 | ||||||||
|
gamma-glutamyl hydrolase | 0.608 | 0.500 | 0.58 |
|
disease | 0.060 | None | 1.000 | 6 | 2 | 2006 | 2019 | ||||||||
|
cytochrome P450 family 3 subfamily A member 5 | 0.511 | 0.846 | 6.3E-17 |
|
disease | 0.060 | None | 0.833 | 6 | 2 | 2002 | 2018 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.050 | None | 0.800 | 5 | 2 | 2010 | 2018 | ||||||||
|
cytochrome P450 family 3 subfamily A member 4 | 0.462 | 0.885 | 5.8E-11 |
|
disease | 0.050 | None | 1.000 | 5 | 2 | 2002 | 2015 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 2 | 2011 | 2019 | ||||||||
|
forkhead box O3 | 0.431 | 0.808 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2013 | 2020 | ||||||||
|
RUNX1 partner transcriptional co-repressor 1 | 0.530 | 0.808 | 0.98 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2005 | 2011 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 2 | 2010 | 2018 |